CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity

Authors

OBERMANNOVA R. DEMLOVÁ Regina SELINGEROVA I. DOUBEK M. OKROUHLICOVA D. MLNAŘÍKOVÁ Marie PILÁTOVÁ Kateřina NEVRLKA J. LEJDAROVÁ Hana WEINBERGEROVA B. CERMAKOVA Z. VALÍK Dalibor MAYER Jiří KISS Igor ZDRAŽILOVÁ DUBSKÁ Lenka

Year of publication 2021
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description SARS-CoV-2 infection may be a threat for those undergoing active anti-cancer therapy. We aim to study adverse events, efficacy, and immune response in Covid-19 vaccinated patients focusing on possibly interfering therapy.

You are running an old browser version. We recommend updating your browser to its latest version.

More info